A single apheresis to achieve a high number of peripheral blood CD34+ cells in a lithium-treated patient with acute myeloid leukaemia

Bone Marrow Transplant. 1999 Feb;23(3):305. doi: 10.1038/sj.bmt.1701566.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antigens, CD34 / analysis
  • Antimanic Agents / pharmacology*
  • Antimanic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bipolar Disorder / complications
  • Bipolar Disorder / drug therapy*
  • Blood Cell Count / drug effects*
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Drug Synergism
  • Etoposide / administration & dosage
  • Female
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Hematopoietic Stem Cell Mobilization*
  • Hematopoietic Stem Cells / drug effects*
  • Humans
  • Idarubicin / administration & dosage
  • Leukapheresis*
  • Leukemia, Monocytic, Acute / blood*
  • Leukemia, Monocytic, Acute / complications
  • Leukemia, Monocytic, Acute / drug therapy
  • Leukemia, Monocytic, Acute / therapy
  • Lithium Carbonate / pharmacology*
  • Lithium Carbonate / therapeutic use
  • Mitoxantrone / administration & dosage
  • Recombinant Proteins
  • Remission Induction
  • Thioguanine / administration & dosage

Substances

  • Antigens, CD34
  • Antimanic Agents
  • Recombinant Proteins
  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Lithium Carbonate
  • Etoposide
  • Mitoxantrone
  • Thioguanine
  • Filgrastim
  • Idarubicin
  • Daunorubicin